Zobrazeno 1 - 10 of 7 629 pro vyhledávání: '"Breccia, M."'
1
Akademický článek
Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trial.
Autor: Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy. f.efficace@gimema.it., Sparano F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., Breccia M; Hematology, Department of Translational and Precision Medicine, University Sapienza Rome, Roma, Italy., Greco C; Division of Hematology, Vicenza, Italy., Carluccio P; Hematology and Bone Marrow Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy., Borlenghi E; Hematology, ASST-Spedali Civili, Brescia, Italy., Salutari P; Haematology, Pescara Hospital, Pescara, Italy., Levato L; SOC. Ematologia AOU 'R. Dulbecco', Catanzaro, Italy., Baldi T; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., Mancini V; Department of Hematology and Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Finizio O; Division of Hematology, Cardarelli General Hospital, Naples, Italy., Autore F; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Fazi P; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., Platzbecker U; Medical Clinic and Polyclinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany., Vignetti M; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., Voso MT; Department of Biomedicine and Prevention, Università di Roma 'Tor Vergata', Rome, Italy.
Publikováno v: Annals of hematology [Ann Hematol] 2024 Oct 23. Date of Electronic Publication: 2024 Oct 23.
Zobrazit plný text záznamu
2
Akademický článek
Different prognosis according to treatment in patients with acute promyelocytic leukemia: How the outcome changed over time.
Autor: Scalzulli E; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., Costa A; Hematology Unit, Department of Medical Sciences and Public Health, Businco Hospital, University of Cagliari, Cagliari, Sardegna, Italy., Carmosino I; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., Musiu P; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., Bisegna ML; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., De Propris MS; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., Ielo C; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., Diverio D; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., Minotti C; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., Capria S; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., Latagliata R; Hematology Unit, Belcolle Hospital, Viterbo, Italy., Martelli M; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy., Breccia M; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I- Sapienza University, Via Benevento 6, Rome, 00161, Italy. breccia@bce.uniroma1.it.
Publikováno v: Annals of hematology [Ann Hematol] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.
Zobrazit plný text záznamu
3
Akademický článek
The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real-world study on AIFA monitoring registries.
Autor: Breccia M; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Celant S; AIFA Italian Medicines Agency, Rome, Italy., Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Passamonti F; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., Olimpieri PP; AIFA Italian Medicines Agency, Rome, Italy., Summa V; AIFA Italian Medicines Agency, Rome, Italy., Guarcello A; AIFA Italian Medicines Agency, Rome, Italy., Palumbo GA; Hematology with BMT Unit, A.O.U. 'G. Rodolico-San Marco', Italy University of Catania, Catania, Italy., Pane F; Università Degli Studi di Napoli Federico II, Naples, Italy., Guglielmelli P; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Corradini P; Università Degli Studi di Milano & Divisione Ematologia, Fondazione IRCCS Istituto Nazionale Dei Tumori di Milano, Milan, Italy., Russo P; AIFA Italian Medicines Agency, Rome, Italy.
Publikováno v: British journal of haematology [Br J Haematol] 2024 Oct 03. Date of Electronic Publication: 2024 Oct 03.
Zobrazit plný text záznamu
4
Akademický článek
Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.
Autor: Bucelli C; Hematology Division, Foundation IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy., Capodanno I; Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy., Miggiano MC; Hematology Department, San Bortolo Hospital, Vicenza, Italy., Cavazzini F; Hematology Unit, University of Ferrara, Ferrara, Italy., Crescenzi SL; Hematology, San Giovanni Hospital, Rome, Italy., Russo S; Hematology, University of Messina, Messina, Italy., Carmosino I; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I-Sapienza University, Rome, Italy., Annunziata M; Hematology Unit, Cardarelli Hospital, Naples, Italy., Sorà F; Institute of Hematology, Policlinico Universitario A. Gemelli, 'Cattolica' University, Rome, Italy., Bonifacio M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy., Luciano L; Hematology, University Federico II, Naples, Italy., Caocci G; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Loglisci G; Hematology, Vito Fazzi Hospital, Lecce, Italy., Elena C; Hematology, Policlinico San Matteo, University of Pavia, Pavia, Italy., Lunghi F; Division of Hematology and BMT, IRCCS San Raffaele Hospital, Milan, Italy., Mullai R; Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy., Attolico I; Hematology and Transplantation Unit, University of Bari, Bari, Italy., Binotto G; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padua, Italy., Crisà E; Hematology, Ospedale Maggiore, Novara, Italy., Sportoletti P; Hematology, University of Perugia, Perugia, Italy., Di Veroli A; Hematology, Belcolle Hospital, Viterbo, Italy., Scortechini AR; Hematology Unit, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy., Leporace AP; Hematology Unit Azienda Ospedaliero Universitaria Sant'Andrea, Roma, Italy., Maggi A; Hematology, San Giuseppe Moscati Hospital, Taranto, Italy., Crugnola M; Hematology, University of Parma, Parma, Italy., Stagno F; Hematology, Ferrarotto Hospital, Catania, Italy., Sancetta R; Hematology Unit, Dell'Angelo Hospital, Venezia-Mestre, Italy., Murgano P; Division of Hematology, Sant'Elia Hospital, Caltanissetta, Italy., Rapezzi D; Hematology, AO Santa Croce e Carle, Cuneo, Italy., Luzi D; Onco-Hematology Department, AO Santa Maria, Terni, Italy., Vincelli DI; Hematology, Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy., Galimberti S; Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy., Bocchia M; Hematology, AOU Senese, Siena, Italy., Fava C; Hematology, Mauriziano Hospital, Torino, Italy., Malato A; Hematology, Cervello Hospital, Palermo, Italy., Abruzzese E; Hematology, Sant'Eugenio Hospital, Roma, Italy., Saglio G; Department of Clinical and Biological Sciences, University of Turin, Torino, Italy., Specchia G; School of Medicine, University of Bari, Bari, Italy., Breccia M; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I-Sapienza University, Rome, Italy., Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy., Tiribelli M; Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy., Latagliata R; Hematology, Belcolle Hospital, Viterbo, Italy.
Publikováno v: European journal of haematology [Eur J Haematol] 2024 Sep 12. Date of Electronic Publication: 2024 Sep 12.
Zobrazit plný text záznamu
5
Akademický článek
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results.
Autor: Cortes JE; Georgia Cancer Center at Augusta University, Augusta, GA, USA. Jorge.Cortes@Augusta.edu., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kim DW; Uijeongbu Eulji Medical Center, Geumo-dong, Uijeongbu-si, South Korea., Hughes TP; South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, SA, Australia., Etienne G; Department of Hematology, Institut Bergonié, Bordeaux, France., Mauro MJ; Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hochhaus A; Hematology/Oncology, Universitätsklinikum Jena, Jena, Germany., Lang F; Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany., Heinrich MC; Portland VA Health Care System and OHSU Department of Medicine, Division of Hematology and Oncology, Knight Cancer Institute, Portland, OR, USA., Breccia M; Department of Translational and Precision Medicine-Az., Policlinico Umberto I-Sapienza University, Rome, Italy., Deininger M; Versiti Blood Research Institute, Milwaukee, WI, USA., Goh YT; Department of Haematology, Singapore General Hospital, Bukit Merah, Singapore., Janssen JJWM; Radboud University Medical Center, Nijmegen, The Netherlands., Talpaz M; Division of Hematology-Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., de Soria VGG; Hospital Universitario La Princesa, Madrid, Spain., le Coutre P; Department of Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany., DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA, USA., Damon A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Cacciatore S; Novartis Pharma AG, Basel, Switzerland., Polydoros F; Novartis Pharma AG, Basel, Switzerland., Agrawal N; Novartis Pharma AG, Basel, Switzerland., Rea D; Department of Hématologie, Hôpital Saint-Louis, Paris, France.
Publikováno v: Leukemia [Leukemia] 2024 Jul; Vol. 38 (7), pp. 1522-1533. Date of Electronic Publication: 2024 May 16.
Zobrazit plný text záznamu
7
Editorial & Opinion
Ruxolitinib after fedratinib failure in patients with myelofibrosis: A real-world case series.
Autor: Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Branzanti F; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Benevolo G; University Hematology Division, Città della Salute e della Scienza Hospital, Torino, Italy., Beggiato E; Unit of Hematology, Department of Oncology, University of Torino, Torino, Italy., Morsia E; Hematology Unit, Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy., Dedola A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Loffredo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Fontana G; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Palumbo GA; Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', University of Catania, Catania, Italy., Breccia M; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Tiribelli M; Division of Hematology and BMT, Department of Medicine, University of Udine, Udine, Italy.
Publikováno v: British journal of haematology [Br J Haematol] 2024 Oct; Vol. 205 (4), pp. 1605-1609. Date of Electronic Publication: 2024 Jul 17.
Zobrazit plný text záznamu
8
Akademický článek
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Autor: Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Palumbo GA; Dipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', Università di Catania, Catania, Italy., Benevolo G; Division of Hematology, Città della Salute e della Scienza Hospital, Torino, Italy., Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Elli EM; IRCCS San Gerardo dei Tintori, Divisione di Ematologia e Unità Trapianto di Midollo, Monza, Italy., Abruzzese E; Hematology, S.Eugenio Hospital, Tor Vergata University, Rome, Italy., Polverelli N; Unit of Blood Diseases and Stem Cell Transplantation, ASST Spedali Civili di Brescia, Brescia, Italy., Tiribelli M; Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy., Auteri G; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Tieghi A; Department of Hematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy., Caocci G; Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy., Binotto G; Unit of Hematology and Clinical Immunology, University of Padova, Padova, Italy., Cavazzini F; Division of Hematology, University of Ferrara, Ferrara, Italy., Branzanti F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Beggiato E; Division of Hematology, Città della Salute e della Scienza Hospital, Torino, Italy., Miglino M; IRCCS Policlinico San Martino, Genova, Italy.; Dipartimento di Medicina Interna e Specialità Mediche, Università di Genova, Genova, Italy., Bosi C; Division of Hematology, AUSL di Piacenza, Piacenza, Italy., Crugnola M; Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy., Bocchia M; Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy., Martino B; Division of Hematology, Azienda Ospedaliera 'Bianchi Melacrino Morelli', Reggio Calabria, Italy., Pugliese N; Department of Clinical Medicine and Surgery, Hematology Section, University of Naples 'Federico II', Naples, Italy., Scaffidi L; Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy., Venturi M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Duminuco A; Postgraduate School of Hematology, University of Catania, Catania, Italy., Isidori A; Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy., Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Krampera M; Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy., Pane F; Department of Clinical Medicine and Surgery, Hematology Section, University of Naples 'Federico II', Naples, Italy., Cilloni D; Haematology Division, Department of Clinical and Biological Sciences, Ospedale San Luigi di Orbassano, University of Turin, Orbassano, Italy., Semenzato G; Unit of Hematology and Clinical Immunology, University of Padova, Padova, Italy., Lemoli RM; IRCCS Policlinico San Martino, Genova, Italy.; Dipartimento di Medicina Interna e Specialità Mediche, Università di Genova, Genova, Italy., Cuneo A; Division of Hematology, University of Ferrara, Ferrara, Italy., Trawinska MM; Hematology, S.Eugenio Hospital, Tor Vergata University, Rome, Italy., Vianelli N; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Bonifacio M; Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy., Breccia M; A.O.U. Policlinico Umberto I, Università degli Studi di Roma 'La Sapienza', Rome, Italy.
Publikováno v: Cancer [Cancer] 2024 Apr 15; Vol. 130 (8), pp. 1270-1280. Date of Electronic Publication: 2023 Dec 28.
Zobrazit plný text záznamu
9
Editorial & Opinion
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.
Autor: Costa A; Hematology Unit, Businco Hospital, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Carmosino I; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Scalzulli E; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Minotti C; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., De Propris MS; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Masucci C; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Passucci M; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Bisegna ML; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Ielo C; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Pepe S; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Diverio D; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Martelli M; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Breccia M; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy.
Publikováno v: European journal of haematology [Eur J Haematol] 2024 Apr; Vol. 112 (4), pp. 654-657. Date of Electronic Publication: 2023 Dec 14.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje